Terumo (TRUMY) & Its Competitors Financial Analysis

Terumo (OTCMKTS:TRUMY) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its rivals? We will compare Terumo to related businesses based on the strength of its analyst recommendations, institutional ownership, earnings, risk, profitability, dividends and valuation.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Terumo and its rivals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Terumo	0	0	0	2	4.00
Terumo Competitors	4302	10596	18377	837	2.46

As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.33%. Given Terumo’s rivals higher probable upside, analysts clearly believe Terumo has less favorable growth aspects than its rivals.

Earnings & Valuation

This table compares Terumo and its rivals revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Terumo	$7.52 billion	$897.03 million	31.35
Terumo Competitors	$1.89 billion	$136.85 million	5.95

Terumo has higher revenue and earnings than its rivals. Terumo is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Terumo and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Terumo	9.31%	7.03%	4.83%
Terumo Competitors	-300.62%	-179.55%	-22.71%

Volatility & Risk

Terumo has a beta of 0.82, suggesting that its stock price is 18% less volatile than the S&P 500. Comparatively, Terumo’s rivals have a beta of 5.41, suggesting that their average stock price is 441% more volatile than the S&P 500.

Insider and Institutional Ownership

40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 14.9% of shares of all “Healthcare Equipment & Supplies” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Dividends

Terumo pays an annual dividend of $0.05 per share and has a dividend yield of 0.3%. Terumo pays out 10.4% of its earnings in the form of a dividend. As a group, “Healthcare Equipment & Supplies” companies pay a dividend yield of 2.2% and pay out 42.0% of their earnings in the form of a dividend.

Summary

Terumo beats its rivals on 9 of the 15 factors compared.

Terumo Company Profile

Terumo Corporation is a Japan-based medical technology company that develops and manufactures products for hospitals, clinics and other healthcare providers. Founded in 1921, the company began by producing clinical thermometers and has since expanded into a broad range of medical devices and services. Terumo’s businesses include cardiovascular and vascular products, such as catheter-based devices and systems used in the treatment of heart and vascular conditions; medical care products, including infusion and injection devices; and blood and cell technologies used to collect, process and manage blood and cellular therapies.